OTTAWA, Sept. 10, 2018 /CNW/ - Today, on World Suicide Prevention Day, we are reminded that everyone can make a contribution to suicide prevention. The Mental Health Commission of Canada (MHCC) is taking concrete steps to help individuals and communities across Canada prevent suicide by building resources and tools, and mobilizing the uptake of best practices. Our work includes:
User-friendly toolkits that provide online resources for people affected by suicide
Online education to help family physicians and nurses increase their capacity to prevent suicide
A #sharehope wall, an online campaign that spreads messages of hope via social media
Roots of Hope, a national community suicide prevention project
Every year in Canada, an estimated 4,000 people take their lives. Suicide affects all ages and people from all walks of life.
Under the theme Working Together to Prevent Suicide, the MHCC joins other partners to ask everyone to come together and remind each other that help, hope and healing are possible. As a national leader in mental health resource and policy development, the MHCC is fulfilling its commitment to meet the needs of people affected by suicide.
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...